Stocks
'Another Hail Mary'—Analysts slam GameStop's (GME) bitcoin gamble
Wedbush analyst Michael Pachter dismissed any hope that GameStop can salvage its core business.
Read more about 'Another Hail Mary'—Analysts slam GameStop's (GME) bitcoin gamble
Chinese self-driving company Pony AI (PONY) slumps as revenue plummets and losses widen
Chinese self-driving company Pony AI (PONY stock) dropped nearly 11% on Tuesday following a disappointing Q4 and full-year 2024 earnings...
Read more about Chinese self-driving company Pony AI (PONY) slumps as revenue plummets and losses widen
SOFI stock is gearing up for the most hated rally of this year
Investors are heavily shorting SoFi Technologies, but analysts say that could be a mistake
Read more about SOFI stock is gearing up for the most hated rally of this year
'Nvidia risks becoming IBM’: Could push for decentralized AI threaten leading chipmakers?
"A $30,000 GPU is not the future of AI," one expert claims
Read more about 'Nvidia risks becoming IBM’: Could push for decentralized AI threaten leading chipmakers?
Shades of Pets.com? 23andMe (ME) plunges 59% into penny stock territory
It sounds almost like something out of the dot-com era: a startup generates a lot of hype, attains an astronomical valuation, goes public... and eventually crashes.
Read more about Shades of Pets.com? 23andMe (ME) plunges 59% into penny stock territory
Solar stocks teeter on the brink in brutal turnaround for residential solar sector
“The overall environment is terrible,” says Sunnova Energy International CEO John Berger
Read more about Solar stocks teeter on the brink in brutal turnaround for residential solar sector
Wall Street is betting big on "low-end" chips
After a prolonged slump, Citi Research analysts are calling for a rebound in the analog semiconductor sector — aka "low-end" chips.
Read more about Wall Street is betting big on "low-end" chips
U.S. airline stocks are plummeting as recession fears grow
While Wall Street grapples with the fallout from President Trump’s tariff policies, another headwind is looming over the horizon
Read more about U.S. airline stocks are plummeting as recession fears grow
U.S. Treasurys don’t provide the same protection they used to, BlackRock CIO says
“The traditional role of bonds as a hedge is no longer reliable,” Rieder said, citing today’s unpredictable interest rate environment.
Read more about U.S. Treasurys don’t provide the same protection they used to, BlackRock CIO says
ProAssurance (PRA) and Optinose (OPTN) soar on M&A news
It turns out the fastest way to please investors this week was to get acquired
Read more about ProAssurance (PRA) and Optinose (OPTN) soar on M&A news
Is the new Assassin’s Creed good enough to save Ubisoft (UBI)?
For French video game publisher Ubisoft (UBI), another flop could mean game over
Read more about Is the new Assassin’s Creed good enough to save Ubisoft (UBI)?
It’s not just Tesla: Wall Street is souring on all American automakers right now
Is a "tariff winter" coming?
Read more about It’s not just Tesla: Wall Street is souring on all American automakers right now
‘Right product at the right time’: Here’s why crypto wallet Exodus Movement (EXOD) is surging
Benchmark analyst Mark Palmer is calling the Exodus Wallet “the right product at the right time” after the Bybit attack
Read more about ‘Right product at the right time’: Here’s why crypto wallet Exodus Movement (EXOD) is surging
'This win is key milestone'—Aeva Technologies (AEVA) soars on major OEM deal and earnings beat
The OEM deal is 'a major validation of the capabilities of our new Atlas Ultra 4D LiDAR sensor,' said Aeva Technologies CEO and co-founder Soroush Salehian
Read more about 'This win is key milestone'—Aeva Technologies (AEVA) soars on major OEM deal and earnings beat
‘Rare among small-cap biotech companies’ — NRx Pharmaceuticals expects to turn profit in 2025
Unveiling its full-year results, NRx went on to confirm that it is planning to request "accelerated approval" of NRx101, which is designed to treat bipolar depression.
Read more about ‘Rare among small-cap biotech companies’ — NRx Pharmaceuticals expects to turn profit in 2025
Celsius’ (CELH) recent rally holding strong as it targets female consumers
Energy drink company Celsius Holdings took a big bet on women and so far it’s paying off for its shareholders
Read more about Celsius’ (CELH) recent rally holding strong as it targets female consumers
Sarepta (SRPT) stock plunges after patient’s death, adding to biotech’s struggles
Regulatory approval gave Sarepta a boost last year — but this year is different
Read more about Sarepta (SRPT) stock plunges after patient’s death, adding to biotech’s struggles
‘Recovering year’— NIU Technologies says it will turn profit this year
NIU CFO Zhou Wenjuan says 2025 will be a "recovering year" for the company
Read more about ‘Recovering year’— NIU Technologies says it will turn profit this year
Benzo bump and short seller target? Hesai (HSAI) is on wild rollercoaster
This marks “the first time a foreign automaker has sought to use such Chinese-made technology for models sold outside China.”
Read more about Benzo bump and short seller target? Hesai (HSAI) is on wild rollercoaster
Is Unusual Machines (UMAC) ultimate Trump-proof drone stock?
Unusual Machines could take the lead in a post-China drone market
Read more about Is Unusual Machines (UMAC) ultimate Trump-proof drone stock?
